Scholay

学术搜索 · AI 审稿 · LaTeX 协作

Prophylactic treatment can modify vascular risk biomarkers in high-frequency episodic and chronic migraine patients: a pilot study

作者:Cristina González‐Mingot, Sonia Santos Lasaosa, Laura Colàs‐Campàs, Laura Chilangua Canaval, Anna Gil-Sánchez, Luís Brieva, María Cristina Marzo Alonso, Sílvia Peralta, Joan Valls, Serafí Cambray, Francisco Purroy · 发表于:Scientific Reports · 年份:2023 · DOI:10.1038/s41598-023-44522-8 · 被引用次数:1 · 研究领域:Migraine and Headache Studies、Cardiovascular Syncope and Autonomic Disorders、Neuroscience of respiration and sleep

To evaluate whether preventive treatment can modify endothelial and oxidative biomarkers of vascular disease risk in patients with high-frequency episodic and chronic migraine. In this observational, prospective pilot study, 88 prophylactic treatment-naïve patients with episodic and chronic migraine and 56 healthy sex/age matched controls underwent ultrasonography exams and blood tests at baseline, and again in the migraine patients after 3 months' treatment with metoprolol or topiramate. Biomarkers for endothelial function and oxidative stress were analyzed. At baseline, patients with migraine in the low-frequency episodic group had differences exclusively in nitrates 17.6 versus 27.33 µM; p = 0.046 compared to the controls. However, when comparing the group comprised of patients with high-frequency episodic migraine and chronic migraine versus controls, statistically significant differences appeared in hsCRP 2.68 versus 1.64 mg/dL; p = 0.049, vWF antigen (133% vs. 110%; p = 0.020, vWF activity (111% vs. 90%; p = 0.010) and isoprostane levels (181 vs. 238 µM; p = 0.05). Only in the chronic migraine subgroup did we found statistically significant differences in CIMT (0.60 vs. 0.54 mm; p = 0.042) which were significantly greater than in the controls. After treatment, patients who respond to preventive treatment exhibited significantly higher levels of nitrates (24.2-13.8 µM; p = 0.022) and nitrites (10.4-3.43 µM; p = 0.002) compared than non-responders. Moreover, biomarker lev...